Dietrich, Pierre-Yves

 
Title Year Hits Downloads
Identification of tumor antigens among the HLA peptidomes of glioblastoma tumors and plasma 2019 18 0
Peptides as cancer vaccines 2019 17 0
Current strategies for vaccination in glioblastoma 2019 13 0
Phase I/II trial testing safety and immunogenicity of the multipeptide IMA950/poly-ICLC vaccine in newly diagnosed adult malignant astrocytoma patients 2019 87 43
Actively personalized vaccination trial for newly diagnosed glioblastoma 2019 13 2
Exploratory study of the effect of IMA950/poly-ICLC vaccination on response to bevacizumab in relapsing high-grade glioma patients 2019 23 6
De sérieuses préoccupations qui ne cachent pas nos espoirs 2019 12 0
Low 5-year cumulative incidence of post-transplant lymphoproliferative disorders after solid organ transplantation in Switzerland 2018 93 31
Diagnosis and treatment of follicular lymphoma: an update 2018 117 67
Prolonged Versus Short-Duration Use of Nasogastric Tubes in Patients with Head and Neck Cancer During Radiotherapy Alone or Combined Chemoradiotherapy 2018 82 64
« Docteur, je jeûne lors de la chimiothérapie » : illusion ou nouvelle réalité clinique ? 2018 73 37
Primordial germ cells as a potential shared cell of origin for mucinous cystic neoplasms of the pancreas and mucinous ovarian tumors 2018 133 5
De vrais espoirs et de sérieuses préoccupations 2018 57 2
Antigenic expression and spontaneous immune responses support the use of a selected peptide set from the IMA950 glioblastoma vaccine for immunotherapy of grade II and III glioma 2018 228 83
Immune Checkpoint Inhibitor-Associated Myocarditis: A New Challenge for Cardiologists 2018 168 2
CAR T-Cell Therapies in Glioblastoma: A First Look 2018 128 0
Responsiveness to anti-PD-1 and anti-CTLA-4 immune checkpoint blockade in SB28 and GL261 mouse glioma models 2018 13 0
Learning from the past to design better trials in second-line treatment for mesothelioma patients 2018 14 1
Identification of Tumor Antigens Among the HLA Peptidomes of Glioblastoma Tumors and Plasma 2018 92 1
Prophylactic Cranial Irradiation in Stage III Non-Small-Cell Lung Cancer: Overall Survival Should Not Necessarily Be the Final End Point 2018 81 0
ER-mitochondria contacts control surface glycan expression and sensitivity to killer lymphocytes in glioma stem-like cells 2017 239 7
A genetic polymorphism repurposes the G-protein coupled and membrane-associated estrogen receptor GPER to a transcription factor-like molecule promoting paracrine signaling between stroma and breast carcinoma cells 2017 190 55
L’accès à l’innovation 2017 113 0
Identification of a novel population of highly cytotoxic c-Met-expressing CD8(+) T lymphocytes 2017 210 3
Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial 2017 129 1
Immunothérapie des gliomes : illusion ou espoir ? 2017 85 0
Early closure of fistula using neo-adjuvant intra-arterial chemotherapy in locally advanced anal cancer 2017 181 0
8th Santorini Conference: Systems medicine and personalized health and therapy, Santorini, Greece, 3-5 October 2016 2017 182 3
BRAF/MEK double blockade in refractory anaplastic pleomorphic xanthoastrocytoma 2017 191 66
Glut3 Addiction Is a Druggable Vulnerability for a Molecularly Defined Subpopulation of Glioblastoma 2017 114 4
Management of central nervous system involvement in chronic lymphocytic leukaemia: a retrospective cohort of 30 patients 2017 142 0
First report of clinical responses to immunotherapy in 3 relapsing cases of chordoma after failure of standard therapies 2017 236 7
Cell-penetrating peptides-the Swiss Army knife of cancer vaccines 2016 291 129
Progrès dans l’immunothérapie des tumeurs cérébrales : difficultés et perspectives 2016 99 2
Immunotherapy of Malignant Tumors in the Brain: How Different from Other Sites? 2016 155 89
Medulloblastoma in children and adults: one distinct disease entity? 2016 145 16
Decitabine Treatment of Glioma-Initiating Cells Enhances Immune Recognition and Killing 2016 230 437
Enhancing Antitumor Immune Responses by Optimized Combinations of Cell-penetrating Peptide-based Vaccines and Adjuvants 2016 286 55
Patterns of care in recurrent glioblastoma in Switzerland: a multicentre national approach based on diagnostic nodes 2016 157 108
Hypoxia and antitumor CD8(+) T cells: An incompatible alliance? 2016 160 69
Outcome of patients with nonmetastatic muscle-invasive bladder cancer not undergoing cystectomy after treatment with noncisplatin-based chemotherapy and/or radiotherapy: a retrospective analysis 2016 230 70
Ipilimumab-related hypophysitis may precede severe CNS immune attack 2016 150 0
Human tissue engineering allows the identification of active miRNA regulators of glioblastoma aggressiveness 2016 168 1
Phenotypic switch of CD8(+) T cells reactivated under hypoxia toward IL-10 secreting, poorly proliferative effector cells 2015 177 2
Glioblastoma adaptation traced through decline of an IDH1 clonal driver and macro-evolution of a double-minute chromosome 2015 141 35
Chimiothérapie de maintenance : futile ou utile ? 2015 160 30
Recurrent multiple CNS hemangioblastomas with VHL disease treated with pazopanib: a case report and literature review 2015 219 0
La société face au cancer : prises de conscience et initiatives citoyennes 2015 118 29
Lymphome cérébral : une présentation classique ? 2015 142 67
Novel Cell-Penetrating Peptide-Based Vaccine Induces Robust CD4+ and CD8+ T Cell-Mediated Antitumor Immunity 2015 248 4
Aggressiveness of cancer treatment in patients hospitalized in a supportive care unit 2015 333 1
Immunotherapy of Brain Tumors 2015 191 0
Phase I study of sorafenib combined with radiation therapy and temozolomide as first-line treatment of high-grade glioma 2014 183 1
Injecting hope into brain cancer treatment: is immunotherapy the way forward? 2014 100 0
Immunotherapy for glioma: from illusion to realistic prospects? 2014 718 274
Création du Centre du cancer de la prostate des HUG 2014 376 2
Extrachromosomal driver mutations in glioblastoma and low-grade glioma 2014 353 37
Comprehensive metagenomic analysis of glioblastoma reveals absence of known virus despite antiviral-like type I interferon gene response 2014 362 176
Fine-needle aspiration biopsy for the diagnosis of metastatic type B thymoma to lymph nodes: A case report 2014 331 1
Phase 2 trial of single-agent everolimus in chemotherapy-naive patients with castration-resistant prostate cancer (SAKK 08/08) 2013 252 0
Synergy between CD8 T cells and Th1 or Th2 polarised CD4 T cells for adoptive immunotherapy of brain tumours 2013 339 172
The relationship between brain tumor cell invasion of engineered neural tissues and in vivo features of glioblastoma 2013 345 5
Maximizing output from current glioma vaccine trials to construct robust next-generation immunotherapies 2013 273 0
Neuropathies associées aux paraprotéinémies (gammapathies monoclonales) 2013 139 0
Radioimmunotherapy combined with maintenance anti-CD20 antibody may trigger long-term protective T cell immunity in follicular lymphoma patients 2013 280 332
Natural HLA class I ligands from glioblastoma: extending the options for immunotherapy 2013 326 0
A multicenter phase II trial (SAKK 36/06) of single-agent everolimus (RAD001) in patients with relapsed or refractory mantle cell lymphoma 2012 279 240
A prospective study of the factors shaping antibody responses to the AS03-adjuvanted influenza A/H1N1 vaccine in cancer outpatients 2012 322 0
Complete remission with tyrosine kinase inhibitors in renal cell carcinoma 2012 308 261
Multipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survival 2012 257 2
MGMT methylation analysis of glioblastoma on the Infinium methylation BeadChip identifies two distinct CpG regions associated with gene silencing and outcome, yielding a prediction model for comparisons across datasets, tumor grades, and CIMP-status 2012 272 858
Plasmablastic lymphoma clinically presenting in the urinary tract 2012 316 0
Exploiting the glioblastoma peptidome to discover novel tumour-associated antigens for immunotherapy 2012 309 459
Takotsubo syndrome secondary to adrenal adenocarcinoma: cortisol as a possible culprit 2012 324 4
Visceral Kaposi's Sarcoma Related to Human Herpesvirus-8 in Liver Transplant Recipient: Case Report and Literature Review 2012 300 153
Impact of synthetic and biologic disease-modifying antirheumatic drugs on antibody responses to the AS03-adjuvanted pandemic influenza vaccine: a prospective, open-label, parallel-cohort, single-center study 2011 392 7
Gastrointestinal relapse of multiple myeloma and sustained response to lenalidomide: a case report 2011 316 31
Recurrent Syncope due to Esophageal Squamous Cell Carcinoma 2011 338 135
Soin nutritionnel intégré au soin oncologique : un besoin d'optimisation 2011 544 354
Oncology ESAB 2011 2011 324 8
Delayed but Complete Response following Oral Temozolomide Treatment in Melanoma Leptomeningeal Carcinomatosis 2011 343 0
Graft-versus-host disease is the major determinant of humoral responses to the AS03-adjuvanted influenza A/09/H1N1 vaccine in allogeneic hematopoietic stem cell transplant recipients 2011 603 383
Prevention of CNS relapse in diffuse large B-cell lymphoma 2011 269 0
Cooperative expression of junctional adhesion molecule-C and -B supports growth and invasion of glioma 2010 327 1
Immune infiltration of spontaneous mouse astrocytomas is dominated by immunosuppressive cells from early stages of tumor development 2010 323 3
Phase I/IIa study of cilengitide and temozolomide with concomitant radiotherapy followed by cilengitide and temozolomide maintenance therapy in patients with newly diagnosed glioblastoma 2010 298 0
Long-term follow-up of patients with follicular lymphoma receiving single-agent rituximab at two different schedules in trial SAKK 35/98 2010 273 0
T-cell immunotherapy for malignant glioma: toward a combined approach 2010 338 2
Marker-independent identification of glioma-initiating cells 2010 252 0
Vaccination of melanoma patients with Melan-A/Mart-1 peptide and Klebsiella outer membrane protein p40 as an adjuvant 2009 296 1
Intrathecal MTX for DLBCL: from an inappropriate prophylactic tradition to a medical error? 2009 283 1
Limits of CD133 as a marker of glioma self-renewing cells 2009 275 0
Tumors that look for their springtime in APRIL 2009 293 0
Diagnostic precision of image-guided multisampling core needle biopsy of suspected lymphomas in a primary care hospital 2009 307 0
Generalized xerotic dermatitis with neutrophilic spongiosis induced by erlotinib (Tarceva) 2008 251 1
Management of malignant pleural effusion and ascites by a triple access multi perforated large diameter catheter port system 2008 483 293
Peripheral tolerance limits CNS accumulation of CD8 T cells specific for an antigen shared by tumor cells and normal astrocytes 2008 283 9
Frequently asked questions in the medical management of high-grade glioma: a short guide with practical answers 2008 253 0
Bevacizumab/Irinotecan. Un nouveau traitement actif dans les gliomes de haut grade récidivants : résultats préliminaires d'une étude multicentrique de l'Anocef 2008 302 0
Stem cell-related "self-renewal" signature and high epidermal growth factor receptor expression associated with resistance to concomitant chemoradiotherapy in glioblastoma 2008 335 2
Bevacizumab therapy before autologous stem-cell transplantation for POEMS syndrome 2008 266 0
Percutaneous cementoplasty in multiple myeloma: a valuable adjunct for pain control and ambulation maintenance 2008 316 36
Bortezomib-induced skin eruption 2008 265 2
Expression and localization of VEGF-C and VEGFR-3 in glioblastomas and haemangioblastomas 2006 310 0
Cytomegalovirus colitis--a severe complication after standard chemotherapy 2002 286 0
24082 5880